Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Carcinoma cells, introns

F. Role in therapy According to Micromedex, Roferon-A is recommended as the drug of choice in renal carcinoma and the chronic phase of chronic myelogenous leukemia. The role of Gleevec (Ima-tinib) in CML is yet to be determined, but it may replace the use of interferon alfa-2a. Roferon-A is an alternative (for unrespon-sive/intolerant patients) to current regimens of choice in hairy-cell leukemia, multiple myeloma, metastatic melanoma, and AIDS-related Kaposi s sarcoma. Other alpha interferons appear to have similar efficacy and can be used in lieu of Roferon-A in some instances. In particular, interferon alfa-2b (Intron) can be considered to have the same role as interferon alfa-2a in chronic hepatitis C, Kaposi s sarcoma, and hairy-cell leukemia. [Pg.191]

See other pages where Carcinoma cells, introns is mentioned: [Pg.1877]    [Pg.66]    [Pg.280]    [Pg.482]    [Pg.348]    [Pg.128]    [Pg.156]    [Pg.228]    [Pg.236]    [Pg.140]    [Pg.190]    [Pg.214]    [Pg.282]    [Pg.416]    [Pg.470]    [Pg.531]    [Pg.582]    [Pg.585]    [Pg.595]    [Pg.726]    [Pg.17]    [Pg.17]    [Pg.2028]   
See also in sourсe #XX -- [ Pg.280 , Pg.281 , Pg.282 ]



SEARCH



Carcinoma cells

© 2024 chempedia.info